Covaxin trials in the U. S. have been halted
The Phase 2/3 clinical trials of Bharat Biotech’s COVID-19 vaccine Covaxin in the United States have been halted by the United States Food and Drug Administration (USFDA). Ocugen, Bharat Biotech’s US partner, stated in a … Read more